Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Elan Stock Keeps Rising Despite Denial of BMS Takeover
- Elan's stock continues to float on the idea that BMS is about to buy some or all of the company. by Jim Edwards
- Blog posts 2009-06-02
Additional Resources
- Elan woes may open opportunities for Biogen, Wyeth
- By Toni Clarke - Analysis BOSTON (Reuters) - Elan Corp Plc's (ELN.I)(ELN.N) move to explore strategic options, including a sale or merger of the company, puts Biogen Idec Inc(BIIB.O) and Wyeth(WYE.N) in prime position to do a deal with the Irish drugmaker. That is, assuming Elan can get any deal...
- News items 2009-08-07
- Elan "Poison Pill" Deal With Biogen Prevents Rumored Pfizer Takeover
- Elan ended a rally in its stock last week when CEO Kelly Martin said the company was NOT negotiating to sell itself to Pfizer. Oddly, most coverage of the event -- the rumor-fueled stock runup and the bursting of Elan's bubble -- didn't mention the reason why Kelly was so...
- Blog posts 2009-01-12
- Ireland's Elan hires Citi to weigh sale of company
- By Ben Hirschler and Andras Gergely LONDON/DUBLIN (Reuters) - Elan Corp Plc (ELN.I) has hired Citigroup to conduct a strategic review that could lead to a sale or merger of the company, Ireland's top drugmaker said on Tuesday, sending its shares sharply higher. The move follows criticism from some major...
- News items 2009-08-07
- Elan "Will Run Out of Money in 2 Years"
- The clock is ticking for Elan Pharmaceuticals. Despite predicting it will record $1 billion in revenue in 2008, the company could run out of money in two years. The company is considering closing two U.S. facilities because its multiple sclerosis drug Tysabri is growing more slowly and doctors are worrying...
- Blog posts 2008-11-19
- Stock movers of note 2/28/2005.
- M2 PRESSWIRE-28 February 2005-StreetInsider.com: Stock movers of note 2/28/2005C1994-2005 M2 COMMUNICATIONS LTD RDATE:28022005 StreetInsider.com's Stock Movers of Note: Elan Corporation, plc (NYSE: ELN), Retek Inc. (Nasdaq: RETK), Biogen Idec (NASDAQ: BIIB), Millennium Cell (Nasdaq: MCEL), USF Corp. (Nasdaq: USFC), Bradley ...
- Research articles 2005-02-28
- Elan Corp. to buy Dura Pharmaceuticals Inc. for 5.64 times revenue, The
- The Deal: The Elan Corp., an Irish drug maker, has agreed to purchase Dura Pharmaceuticals Inc. in a stock deal valued at $1.7 billion. The transaction continues Elan's aggressive trans-Atlantic buying spree. The acquisition will launch Elan into the respiratory and antibiotic therapy areas. Along with the expansion of products,...
- Research articles 2000-09-25
- Elan Completes Sale of Its Remaining Stockholding in Athena Diagnostics for $82 Million in Cash
- Business Editors DUBLIN, Ireland--BUSINESS WIRE--Dec. 31, 2002 Elan Corporation, plc (NYSE: ELN) ("Elan"), together with the other stockholders of Elan's subsidiary, Athena Diagnostics, Inc. ("Athena Diagnostics"), have completed the sale of all of the outstanding stock of Athena Diagnostics to Behrman Capital ("Behrman") and certain of its affiliated...
- Research articles 2002-12-31
- Latest Elan moves fail to restore confidence. (News).(Brief Article)
- THE BELEAGUERED Irish pharmaceutical firm Elan Corp. announced last week a further shakeup in its top management and a plan to infuse cash into its balance sheet. Saddled with debt and struggling from the collapse of its stock following allegations THE BELEAGUERED Irish pharmaceutical...
- Research articles 2002-07-15
- Elan to Sell Its Remaining Stockholding in Athena Diagnostics and Realise $82 Million in Cash
- Business Editors DUBLIN, Ireland--BUSINESS WIRE--Nov. 22, 2002 Elan Corporation, plc (NYSE: ELN) ("Elan"), together with the other stockholders of Elan's subsidiary, Athena Diagnostics, Inc. ("Athena Diagnostics"), have agreed to sell all of the outstanding stock of Athena Diagnostics to Behrman Capital ("Behrman") and certain of its affiliated investment...
- Research articles 2002-11-22
- Stock Movers of Note 03/31.
- M2 PRESSWIRE-31 March 2005-StreetInsider.com: Stock Movers of Note 03/31C1994-2005 M2 COMMUNICATIONS LTD RDATE:31032005 Streetinsider.com's Stock Movers of Note: Elan Corporation, plc (NYSE: ELN), Biogen Idec (NASDAQ: BIIB), Bookham, Inc. (Nasdaq: BKHM), Nortel Networks Corporation (NYSE: NT), Haggar Clothing Co (Nasdaq:...
- Research articles 2005-03-31
- Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity
- A. Reza Saadat submits: In July, Biogen-Idec BIIB and Elan ELN, who co-market the multiple sclerosis drug Tysabri, announced two new cases of PML, a potentially deadly side effect. The stocks sold-off almost entirely. Biogen-Idec lost about 30% of its market share while Elan has lost over two thirds...
- External links 2008-08-10
- New ratings on United Microelectronics, Elan, Mellon Financial, Kraft Foods, and United Technologies.
- M2 PRESSWIRE-19 July 2002-StockPickReport.Com: New ratings on United Microelectronics, Elan, Mellon Financial, Kraft Foods, and United Technologies C1994-2002 M2 COMMUNICATIONS LTD RDATE:07192002 StockPickReport.Com (IARD#119079 - http://www.stockpickreport.com/?src=n3 ) makes these stock evaluations for the short term: ...
- Research articles 2002-07-19
- Elan Energy Inc. Closes Common Share Issue
- CALGARY, Alberta--BUSINESS WIRE--June 4, 1996--Elan Energy Inc. (TSE, ME: ELN )("ELAN") announces that it has closed today the issuance of 7,000,000 Common Shares at $13.00 per Common Share for aggregate gross proceeds of $91,000,000 pursuant to its previously announced bought deal financing. The listing of the 7,000,000 Common Shares...
- Research articles 1996-06-04
- A Bull's on the Loose at Elan
- Mike Huckman submits: Don't look now, but in the first week of the new year shares of Elan ELN are up 30 percent. ELN stock lost nearly three-quarters of its value last year on safety concerns about the multiple sclerosis drug Tysabri, which it shares with Biogen Idec BIIB,...
- External links 2009-01-08
- Elan-Pfizer Deal Rumor Is Deja Vu All Over Again
- Elan got back on the takeover merry-go-round again today, with its stock rising on rumors that Pfizer might be interested in buying the company. Elan investors had just gotten off that ride a few days ago with the news that Bristol-Myers Squibb and Lundbeck were not, in fact, trying to...
- Blog posts 2009-06-05
- Zacks.com Announces That Nadine Wong Highlights: Biogen-Idec and Elan
- CHICAGO -- Nadine Wong, editor of the BioTech Stock Report newsletter, explains that a third case of PML (progressive multi-focal leukoencephalopathy) has been linked to Tysabri. Learn about this drug as well as Biogen-Idec (NASDAQ:BIIB) and Elan (NYSE:ELN). Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84 Highlights...
- Research articles 2005-04-12
- Elan to File Interim Six Month Irish GAAP Financials with the Dublin and London Stock Exchanges; Interim Results to Include a Reserve for Shareholder Lawsuit and SEC
- DUBLIN, Ireland -- Elan Corporation, plc today announced that it will file its interim results for the six months ended 30 June 2004, prepared under Irish GAAP, with the Dublin and London Stock Exchanges this week.
- Research articles 2004-10-04
- Elan Announces the Suspension of Trading of Its Shares Commencing March 7, 2006 For Up to Two Days; Suspension of Trading Due to Two Day FDA Advisory Committee Meeting to Review Tysabri
- DUBLIN, Ireland -- Elan Corporation, plc today announced it has agreed with the Irish Stock Exchange ISE, the Financial Services Authority in the United Kingdom and the New York Stock Exchange NYSE to suspend trading of its securities ADRs and ordinary shares during the scheduled U.S. Food and Drug Administration...
- Research articles 2006-02-28
- New ratings on Mcdonalds, Linear Technology, Bank One, Elan, and Barrick Gold.
- M2 PRESSWIRE-22 March 2002-StockPickReport.Com: New ratings on Mcdonalds, Linear Technology, Bank One, Elan, and Barrick Gold C1994-2002 M2 COMMUNICATIONS LTD RDATE:22032002 StockPickReport.Com ( http://www.stockpickreport.com ) gives you these stock evaluations for the short term: FREE Stock...
- Research articles 2002-03-22
- << Previous
- page 1 of 1
- Next >>
